Biology Reference
In-Depth Information
poetin alfa in lung cancer patients receiving chemotherapy.
J Natl Cancer Inst
94: 1211-1220
30 Seidenfeld J, Piper M, Flamm C, Hasselblad V, Armitage JO, Bennett CL, Gordon MS, Lichtin
AE, Wade JL 3rd Woolf S et al. (2001) Epoetin treatment of anemia associated with cancer ther-
apy:A systematic review and meta-analysis of controlled clinical trials.
J Natl Cancer Inst
93:
1204-1214
31Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ,
Jakubowski AA, Lee SJ et al. (2002) Use of epoetin in patients with cancer: Evidence-based clin-
ical practice guidelines of the American Society of Clinical Oncology and the American society
of hematology.
J Clin Oncol
20: 4083-4107
32Glaspy JA, Jadeja JS, Justice G, Kessler J, Richards D, Schwartzberg L, Tchekmedyian NS,
Armstrong S, O'Byrne J, Rossi G et al. (2002) Darbepoetin alfa given every 1 or 2 weeks allevi-
ates anaemia associated with cancer chemotherapy.
Br J Cancer
87: 268-276
33 Hedenus M, Hansen S, Taylor K, Arthur C, Emmerich B, Dewey C, Watson D, Rossi G, Osterborg
A,The Darbepoetin alfa 990114 Study Group (2002) Randomized, dose-finding study of darbe-
poetin alfa in anaemic patients with lymphoproliferative malignancies.
Br J Haematol
119: 79-86
34 Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, Itri LM, Johnson DH,
Scherr SL, Portenoy RK (1997) Patient, caregiver, and oncologist perceptions of cancer-related
fatigue: Results of a tripart assessment survey. The Fatigue Coalition.
Semin Hematol
34: 4-12
35 Curt GA (2000) Cancer-related fatigue. The next clinical challenge.
Oncology
15: 7-11
36 Curt GA, Breitbart W, Cella D, Groopman JE, Horning SJ, Itri LM, Johnson DH, Miaskowski C,
Scherr SL, Portenoy RK et al. (2000) Impact of cancer-related fatigue on the lives of patients: New
findings from the fatigue coalition.
Oncologist
5:353-360
37 Crawford J, Cella D, Cleeland CS, Cremieux PY, Demetri GD, Sarokhan BJ, Slavin MB, Glaspy
JA (2002) Relationship between changes in hemoglobin level and quality of life during
chemotherapy in anemic cancer patients receiving epoetin alfa therapy.
Cancer
95: 888-895
38 Levin NW (1992) Quality of life and hematocrit level.
Am J Kidney Dis
20: 16-20
39 Evans RW (1991) Recombinant human erythropoietin and the quality of life of end-stage renal
disease patients: A comparative analysis.
Am J Kidney Dis
18: 62-70
40 Wolcott DL, Marsh JT, La Rue A, Carr C, Nissenson AR (1989) Recombinant human erythropoi-
etin treatment may improve quality of life and cognitive function in chronic hemodialysis patients.
Am J Kidney Dis
14: 478-485
41 Delano BG (1989) Improvements in quality of life following treatment with r-HuEPO in anemic
hemodialysis patients.
Am J Kidney Dis
14: 14-18
42 Beusterien KM, Nissenson AR, Port FK, Kelly M, Steinwald B, Ware JEJr, (1996) The effects of
recombinant human erythropoietin on functional health and well-being in chronic dialysis
patients.
J Am Soc Nephrol
7: 763-773
43 Barany P, Pettersson E, Konarski-Svensson JK (1993) Long-term effects on quality of life in
haemodialysis patients of correction of anaemia with erythropoietin.
Nephrol Dial Transplant
8:
426-432
44 Casadevall N, Nataf J, Viron B, Kolta A, Kiladjian JJ, Martin-Dupont P, Michaud P, Papo T, Ugo
V,Teyssandier I et al. (2002) Pure red-cell aplasia and antierythropoietin antibodies in patients
treated with recombinant erythropoietin.
N Engl J Med
346: 469-475
45 Falkson CI, Keren-Rosenberg S, Uys A, Falkson G, Stevens K, Vermaak WJ (1994) Recombinant
human erythropoietin in the treatment of cancer-related anaemia.
Oncology
51: 497-501
46 Kasper C, Terhaar A, Fossa A, Welt A, Seeber S, Nowrousian MR (1997) Recombinant human
erythropoietin in the treatment of cancer-related anaemia
. Eur J Haematol
58:251-256
47 Braga M, Gianotti L, Vignali A, Gentilini O, Servida P, Bordignon C, Di Carlo V (1995)
Evaluation of recombinant human erythropoietin to facilitate autologous blood donation before
surgery in anaemic patients with cancer of the gastrointestinal tract.
Br J Surg
82: 1637-1640
48 Braga M, Gianotti L, Gentilini O, Vignali A, Di Carlo V (1997) Erythropoietic response induced
by recombinant human erythropoietin in anemic cancer patients candidate to major abdominal
surgery.
Hepatogastroenterology
44: 685-690
49 Rau B, Schlag PM, Willeke F, Herfarth C, Stephan P, Franke W (1998) Increased autologous blood
donation in rectal cancer by recombinant human erythropoietin (rhEPO).
Eur J Cancer
34:
992-998
50 Smith REJr Jaiyesimi IA, Meza LA, Tchekmedyian NS, Chan D, Griffith H, Brosman S,
Bukowski R, Murdoch M, Rarick M et al. (2001) Novel erythropoiesis stimulating protein (NESP)
for the treatment of anaemia of chronic disease associated with cancer.
Br J Cancer
84: 24-30
